108 related articles for article (PubMed ID: 21396303)
21. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
22. [Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma].
Zhou CZ; Zheng HT; Qiu GQ; Zhang F; He L; Peng ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1804-7. PubMed ID: 17054854
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of microsatellite alteration in colorectal cancer].
Mizunuma H; Takita K; Ooki S; Onda M; Ando Y; Yoshida T; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():443-9. PubMed ID: 9589050
[TBL] [Abstract][Full Text] [Related]
24. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
Prall F; Weirich V; Ostwald C
Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
[TBL] [Abstract][Full Text] [Related]
25. Deletion mapping of 18q in conventional renal cell carcinoma.
Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
[TBL] [Abstract][Full Text] [Related]
26. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas.
González-Aguilera JJ; Herrero MP; Maillo C; Moreno-Azcoita M; Fernández-Peralta AM
Anticancer Res; 1999; 19(2A):1325-9. PubMed ID: 10368694
[TBL] [Abstract][Full Text] [Related]
28. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
29. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
[TBL] [Abstract][Full Text] [Related]
30. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
[TBL] [Abstract][Full Text] [Related]
32. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
Naidoo R; Tarin M; Chetty R
Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
36. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
[TBL] [Abstract][Full Text] [Related]
37. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
[TBL] [Abstract][Full Text] [Related]
38. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
40. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
